STATE STREET CORP - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 418 filers reported holding IMMUNOMEDICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 1.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$310,196,000
+105.0%
3,648,078
-14.6%
0.02%
+90.9%
Q2 2020$151,317,000
+58.6%
4,269,661
-39.7%
0.01%
+37.5%
Q1 2020$95,381,000
-33.5%
7,075,710
+4.3%
0.01%
-20.0%
Q4 2019$143,506,000
+64.2%
6,781,951
+2.9%
0.01%
+42.9%
Q3 2019$87,386,000
-23.0%
6,590,176
-19.4%
0.01%
-12.5%
Q2 2019$113,472,000
-16.5%
8,181,125
+15.6%
0.01%
-27.3%
Q1 2019$135,925,000
+72.2%
7,075,737
+27.9%
0.01%
+57.1%
Q4 2018$78,953,000
-33.7%
5,532,786
-3.2%
0.01%
-22.2%
Q3 2018$119,047,000
-5.6%
5,715,435
+7.3%
0.01%
-18.2%
Q2 2018$126,082,000
+36.5%
5,326,578
-15.8%
0.01%
+37.5%
Q1 2018$92,377,000
-10.6%
6,322,848
-1.2%
0.01%0.0%
Q4 2017$103,374,000
+55.6%
6,396,893
+34.6%
0.01%
+33.3%
Q3 2017$66,419,000
+56.1%
4,751,015
-1.4%
0.01%
+50.0%
Q2 2017$42,549,000
+87.2%
4,818,847
+37.2%
0.00%
+100.0%
Q1 2017$22,730,000
+284.5%
3,513,549
+118.2%
0.00%
+100.0%
Q4 2016$5,911,000
+27.1%
1,610,194
+12.5%
0.00%
Q3 2016$4,651,000
-14.9%
1,431,793
-39.2%
0.00%
-100.0%
Q2 2016$5,463,000
+51.4%
2,354,732
+63.3%
0.00%
Q1 2016$3,609,000
-10.4%
1,442,360
+9.9%
0.00%
Q4 2015$4,029,000
+79.8%
1,312,013
+0.8%
0.00%
Q3 2015$2,241,000
-58.1%
1,301,999
-1.0%
0.00%
-100.0%
Q2 2015$5,347,000
+9.3%
1,315,589
+3.0%
0.00%0.0%
Q1 2015$4,892,000
-20.3%
1,277,338
-0.1%
0.00%0.0%
Q4 2014$6,139,000
+29.5%
1,278,710
+0.3%
0.00%0.0%
Q3 2014$4,740,000
+0.1%
1,275,023
-1.7%
0.00%0.0%
Q2 2014$4,735,000
-14.1%
1,297,298
-0.9%
0.00%0.0%
Q1 2014$5,514,000
-40.6%
1,309,352
-46.5%
0.00%0.0%
Q4 2013$9,277,000
+20.3%
2,447,706
+96.4%
0.00%0.0%
Q3 2013$7,713,000
+16.4%
1,246,151
+2.3%
0.00%0.0%
Q2 2013$6,627,0001,218,4610.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of IMMUNOMEDICS INC shareholders